Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center's status. Updated the page revision to v3.4.1, with the previous revision v3.4.0 removed.
    Difference
    0.5%
    Check dated 2026-02-04T10:21:47.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows a Show glossary option and a legend for color-coded changes (green for additions, red for deletions). It also introduces the latest revision label (Revision: v3.4.0) and a minor capitalization change in 'No FEAR Act Data'.
    Difference
    0.7%
    Check dated 2026-01-28T06:15:35.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.3.4 and omits Revision: v3.3.3, which affects only revision history metadata and does not alter the study's core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:48:29.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    New history entries were added for Contacts/Locations, Study Design, and Study Status, along with a new version (32) and Revision: v3.3.3; the entry for HHS Vulnerability Disclosure was removed.
    Difference
    0.6%
    Check dated 2025-12-23T20:37:05.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The record shows Active, not recruiting. Added Contacts/Locations, Study Design, Study Status, and Recruitment Status sections, with revision v3.3.2 dated 2025-11-19.
    Difference
    0.6%
    Check dated 2025-11-24T21:38:55.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Notice regarding government funding lapse and operating status, previously visible on the page, has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T19:58:57.000Z thumbnail image

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.